A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist’s dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.
It is becoming much more common for patients to be treated with several different medications. It is often necessary for the patient to take them at fixed intervals – a limitation that makes everyday life difficult and increases the risk of doses being skipped or forgotten.
Oliver Lieleg, Professor of Biomechanics and a member of the Munich School of BioEngineering at TUM, and doctoral candidate Ceren Kimna have now developed a process that could serve as the basis for medications containing several active ingredients that would reliably release them in the body in a pre-defined sequence at specified times. “For example, an ointment applied to a surgical incision could release pain medication first, followed by an anti-inflammatory drug and then a drug to reduce swelling,” explains Oliver Lieleg.
One active ingredient after the other
“Ointments or creams releasing their active ingredients with a time delay are not new in themselves,” says Oliver Lieleg. With the drugs currently in use, however, there is no guarantee that two or more active ingredients will not be released into the organism simultaneously.
To test the principle behind their idea, Oliver Lieleg and Ceren Kimna used nanometer-sized silver, iron oxide and gold particles embedded in a special gel-like substance known as a hydrogel. They then used a spectroscopic method to track the exit of the particles from the gel. The particles selected by the researchers have similar motion characteristics within the gel to the particles used to transport real active ingredients, but are easier and cheaper to make.
The special ingredient controlling the nanoparticles is artificial DNA. In nature, DNA is above all the carrier of genetic information. However, researchers are increasingly exploiting another property: The ability of DNA fragments to be combined with great accuracy, both in terms of the types of bonds and their strength, for example to build machines on a nanometer scale.
The DNA cascade: compress and then release at the right instant
The silver particles were released first. In the initial state, the particles were bound together by DNA fragments designed by Lieleg and Kimna using special software. The resulting particle clusters are so large that they are unable to move in the hydrogel. However, when a saline solution is added, they separate from the DNA. They can now move in the gel and drift to the surface. “Because the saline solution has approximately the same salinity as the human body, we were able to simulate conditions where the active ingredients would not be released until the medication is applied,” explains Ceren Kimna.
The mesh-like DNA structure surrounding the iron oxide particles consists of two types of DNA: The first has one end attached to the iron oxide particles. The second type is attached to the loose ends of the first type. These structures are not affected by the saline solution. The iron oxide particles can only be released when the first clusters have dissolved. This event releases not only the silver nanoparticles, but also DNA, which eliminates the “connection DNA” of the second cluster without forming connections itself. As a result, the iron oxide particles can separate. This releases DNA fragments which in turn act as the key to the third DNA-nanoparticle combination.
“The consistency of ointments makes them the most obvious solution for a hydrogel-based approach. However, this principle also has the potential to be used in tablets that could release several effective ingredients in the body in a specific order,” explains Prof. Lieleg.
Learn more: One at a time
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Global Nanotechnology Drug Delivery Market 2019 Industry Segmentation, CAGR Status, Leading Trends, and Forecast To 2025on April 7, 2020 at 3:59 am
The report provides rational insights along with historical and forecast data to said in better understanding of ...
- Hot Biotech, Stock Symbol: CURR is the New Drug Delivery Company that Improves Efficiency, Safety and Patient Experienceon April 6, 2020 at 10:05 am
Patent on Oral Thin Films for Erectile Disfunction Market in China. Vertically Integrated Drug Delivery Company with Proprietary Products. Major New ...
- Drug Delivery Devices Market to Garner $26.74 Bn, Globally, by 2026 at 4.3% CAGR, Says Allied Market Researchon April 6, 2020 at 6:50 am
Allied Market Research recently published a report, titled, "Drug Delivery Devices Market by Device Type (Smart Pills, Inhalers & ...
- Injectable Drug Delivery Market 2020 Demand, Size, Growth Research Report by 2025on April 6, 2020 at 4:41 am
New York, April 06, 2020: The scope of the report includes a detailed study of global and regional markets on Global Injectable Drug Delivery Market with the reasons given for variations in the growth ...
- Readers respond: Prioritize food and drug deliveryon April 3, 2020 at 5:05 pm
I am 74. And of course, many people can’t afford to pay for delivery. Food and drug delivery should be a government public-safety priority. State and local governments should help pay for and ...
- Fatty acid in triglycerides proves an effective platform for biological drug deliveryon April 1, 2020 at 11:02 am
Houston Methodist nanomedicine researchers are studying this new drug delivery system for a diabetes drug that resulted in approximately 25% absorption in mice models, which is considered to be very ...
- Transdermal Drug Delivery Systems Market Size Is Expected to Exhibit a CAGR of 4.6% By 2023on March 31, 2020 at 10:23 am
The Global Transdermal Drug Delivery Systems Market size was valued USD 5,400.2 million in 2017 and expected to exhibit a CAGR of 4.6% by 2023 owing to the non-invasive nature of these devices. The ...
- Electronic Drug Delivery Systems Marketon March 30, 2020 at 10:21 am
Global electronic drug delivery systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 15.31 Billion ...
- Transdermal Drug Delivery Systems Market To Reach USD 8.39 Billion By 2027on March 27, 2020 at 4:42 am
According to the current analysis of Reports and Data, the Global Transdermal Drug Delivery Systems Market was valued at USD 5.9 Billion in 2019 and is anticipated to reach USD 8.39 Billion by the ...
- Emerging Drug Delivery Systems for Posterior Segment Diseaseon March 26, 2020 at 5:56 pm
The eye, despite its diminutive size of roughly 8 grams, is a tremendous target for drug delivery systems. The anatomic accessibility of the eye and the capacity to directly visualize and image ocular ...
via Bing News